Omega Diagnostics Group PLC
ODX.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£3,860 | -£11,333 | -£2,104 | -£6,828 |
| Dep. & Amort. | £591 | £1,289 | £886 | £1,152 |
| Deferred Tax | £688 | £0 | -£1,298 | £6,440 |
| Stock-Based Comp. | £78 | £282 | £270 | £54 |
| Change in WC | -£665 | £1,465 | -£392 | -£522 |
| Other Non-Cash | £16 | £5,068 | £218 | £252 |
| Operating Cash Flow | -£3,152 | -£3,229 | -£2,420 | £548 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£153 | -£1,478 | -£2,825 | -£2,154 |
| Net Acquisitions | £5,315 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £19 | £985 | £0 | £0 |
| Investing Cash Flow | £5,181 | -£493 | -£2,825 | -£2,154 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £2,200 | £68 | £11,856 | £2,343 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £1,486 | -£502 | £11,074 | £1,636 |
| Financing Cash Flow | £1,486 | -£502 | £11,074 | £1,636 |
| Forex Effect | -£5 | £2 | -£2 | -£30 |
| Net Chg. in Cash | £3,510 | -£4,222 | £5,827 | £0 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1,605 | £5,827 | £0 | £0 |
| End Cash | £5,115 | £1,605 | £5,827 | £0 |
| Free Cash Flow | -£3,305 | -£4,707 | -£5,244 | -£1,606 |